Suaring, Melfred P.

HRN: 27-58-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFTAZIDIME 1GM (VIAL)
08/06/2025
08/13/2025
IV
2g
Q8h
CAP MR R/o Melioidosis
Remove - Pending Acceptance
08/06/2025
COTRIMOXAZOLE 960MG (TAB)
08/06/2025
08/13/2025
PO
1 Tab
Q8h
CAP MR R/o Melioidosis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: